GlassScriptPhysician profile
Charles James Bailey
NPI 1265619365
$162,320.67
in general payments reported to CMS, 2019-2025
18 companies · $56K in 2025
The $56K reported for 2025 was more than what 98% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $665 · 2021: $2,363 · 2022: $12K · 2023: $32K · 2024: $59K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $24K · Travel and Lodging: $13K · Food and Beverage: $12K · Consulting Fee: $6,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $91,260.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $24,300.00 |
| Travel and Lodging | $12,758.38 |
| Food and Beverage | $12,083.87 |
| Consulting Fee | $6,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $68,778.96 | 2021-2025 | Zilver Ptx, Zenith, Zilver Vena |
| Penumbra, INC. | $56,322.62 | 2023-2025 | Indigo System, Ruby Coil, Penumbra System |
| Shockwave Medical, INC | $14,747.21 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $12,643.42 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $4,797.74 | 2019-2025 | Zenith Spiral-Z, Zilver Ptx, Zenith |
| Boston Scientific Corporation | $2,501.09 | 2022-2025 | General - Therapies, General - Vascular Intervention, Eluvia |
| W. L. Gore & Associates, INC. | $1,093.36 | 2019-2023 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Getinge USA Sales, LLC | $320.37 | 2019-2024 | Cardioroot |
| Medtronic, INC. | $260.92 | 2021-2025 | Endurant Iis |
| Bolton Medical INC | $202.57 | 2021 | |
| Abbott Laboratories | $173.39 | 2025 | Esprit |
| Medtronic Vascular, INC. | $130.46 | 2020 | |
| Inari Medical, INC. | $123.04 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $92.03 | 2023-2024 | Grafix Pl, Oasis, Pico 14 |
| Esperion Therapeutics, INC. | $54.57 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $28.38 | 2022 | |
| Chiesi USA, INC. | $25.85 | 2024 | Cleviprex, Kengreal |
| Lemaitre Vascular, INC. | $24.69 | 2025 | Pruitt F3 Carotid Shunt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.